Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/18/22 16:19 | 1/13/22 | APTX | Health | Drug | Pharmaceutical Preparations | Miller Joan W. | IL | D | P | 50 | 2.83 | 0 | 18 | New | 18 | D | |||||||||||||||
12/8/21 16:16 | 12/6/21 | APTX | Health | Drug | Pharmaceutical Preparations | Riedel Norbert G | IL | DO | CEO | P | 223 | 2.23 | 0 | 100 | 8 | 1,356 | I | ||||||||||||||
12/6/21 16:16 | 12/2/21 | APTX | Health | Drug | Pharmaceutical Preparations | Khanna Ashish | IL | O | CFO,CBO | P | 102 | 2.26 | 0 | 45 | 12 | 422 | D | ||||||||||||||
11/16/21 17:58 | 11/11/21 | APTX | Health | Drug | Pharmaceutical Preparations | Hombach Robert J. | IL | D | P.am | 192 | 2.40 | 0 | 80 | 54 | 229 | D | |||||||||||||||
11/15/21 18:37 | 11/11/21 | APTX | Health | Drug | Pharmaceutical Preparations | Hombach Robert J. | IL | D | P.m | 192 | 2.40 | 0 | 80 | 54 | 229 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |